Opus Genetics, Inc. — Director's Dealing 2026

Jan 26, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Opus Genetics, Inc. (IRD)
CIK: 0001228627
Period of Report: 2026-01-22

Reporting Person: Jayagopal Ashwath (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-22	Common Stock	A	400000	—	Acquired	525807	Direct

Footnotes

F1: Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.